← Leaderboards
Richard Michael Lopachin
Montefiore Medical Center (Bronx, Ny)
$7,066,222
Attributed
$7,066,222
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $631.2K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,066,222 · 3
By mechanism
R01$6,957,852 · 2
R56$108,370 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Acrylamides”
- Reshan Fernando · Research Triangle Institute$12,835,140
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$10,376,483
- Maisie Ky Lo · Stanford University$6,822,980
- David W. Russell · University Of Texas Sw Med Ctr/Dallas$5,665,631
- Ian A Wilson · Scripps Research Institute, The$5,659,568
- John M Essigmann · Massachusetts Institute Of Technology$2,884,320
Research focus
AcrylamidesNeurotoxicityMediatingProteinsMolecularBaseFundingSiteAdductLaboratory RatNeural DegenerationNeurotoxinsIndexingNerveFunctional DisorderNerve DegenerationExposed Human PopulationCigarette SmokingAcroleinCysteineBinding (Molecular Function)Environmental PollutantsCell InjuryAlzheimer&Apos
Grant awards (25)
The Nerve Terminal as the Site of Action for Type-2 Alkenes$269,926
R01 · FY2015 · ES · contact PI
The Nerve Terminal as the Site of Action for Type-2 Alkenes$105,824
R01 · FY2015 · ES · contact PI
The Nerve Terminal as the Site of Action for Type-2 Alkenes$371,993
R01 · FY2014 · ES · contact PI
The Nerve Terminal as the Site of Action for Type-2 Alkenes$368,235
R01 · FY2013 · ES · contact PI
The Nerve Terminal as the Site of Action for Type-2 Alkenes$375,750
R01 · FY2012 · ES · contact PI
The Nerve Terminal as the Site of Action for Type-2 Alkenes$294,123
R01 · FY2011 · ES · contact PI
The Nerve Terminal as the Site of Action for Type-2 Alkenes$297,094
R01 · FY2010 · ES · contact PI
Molecular Mechanisms of Hexacarbon-Induced Axon Atrophy$328,582
R01 · FY2009 · ES · contact PI
The Nerve Terminal as the Site of Action for Type-2 Alkenes$300,095
R01 · FY2009 · ES · contact PI
Molecular Mechanisms of Hexacarbon-Induced Axon Atrophy$328,582
R01 · FY2008 · ES · contact PI
The Nerve Terminal as the Site of Action for Type-2 Alkenes$300,095
R01 · FY2008 · ES · contact PI
Molecular Mechanisms of Hexacarbon-Induced Axon Atrophy$335,288
R01 · FY2007 · ES · contact PI
Molecular Mechanisms of Hexacarbon-Induced Axon Atrophy$345,302
R01 · FY2006 · ES · contact PI
The Nerve Terminal as a Site of Acrylamide Action$285,890
R01 · FY2006 · ES · contact PI
The Nerve Terminal as a Site of Acrylamide Action$292,770
R01 · FY2005 · ES
Molecular Mechanisms of Hexacarbon-Induced Axon Atrophy$108,370
R56 · FY2005 · ES
The Nerve Terminal as a Site of Acrylamide Action$292,770
R01 · FY2004 · ES
The Nerve Terminal as a Site of Acrylamide Action$292,770
R01 · FY2003 · ES
MOLECULAR MECHANISMS OF HEXACARBON-INDUCED AXON ATROPHY$271,573
R01 · FY2003 · ES
MOLECULAR MECHANISMS OF HEXACARBON-INDUCED AXON ATROPHY$261,047
R01 · FY2002 · ES
NERVE TERMINAL AS A SITE OF ACRYLAMIDE ACTION$234,614
R01 · FY2002 · ES
MOLECULAR MECHANISMS OF HEXACARBON-INDUCED AXON ATROPHY$260,606
R01 · FY2001 · ES
NERVE TERMINAL AS A SITE OF ACRYLAMIDE ACTION$230,957
R01 · FY2001 · ES
MOLECULAR MECHANISMS OF HEXACARBON-INDUCED AXON ATROPHY$257,959
R01 · FY2000 · ES
NERVE TERMINAL AS A SITE OF ACRYLAMIDE ACTION$256,007
R01 · FY2000 · ES